
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, Catherine H Smith, Richard B Warren, Christopher E M Griffiths, BADBIR study group
British Journal of Dermatology, ljaf017, https://doi.org/10.1093/bjd/ljaf017
Related
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with mo...
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for pa...
Application of information theoretic feature selection and machine learning methods for the developm...
0 Comments